BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1608942)

  • 1. Phorbol esters stimulate the phosphorylation of c-Jun but not v-Jun: regulation by the N-terminal delta domain.
    Adler V; Franklin CC; Kraft AS
    Proc Natl Acad Sci U S A; 1992 Jun; 89(12):5341-5. PubMed ID: 1608942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phorbol ester-induced amino-terminal phosphorylation of human JUN but not JUNB regulates transcriptional activation.
    Franklin CC; Sanchez V; Wagner F; Woodgett JR; Kraft AS
    Proc Natl Acad Sci U S A; 1992 Aug; 89(15):7247-51. PubMed ID: 1496019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Affinity-purified c-Jun amino-terminal protein kinase requires serine/threonine phosphorylation for activity.
    Adler V; Polotskaya A; Wagner F; Kraft AS
    J Biol Chem; 1992 Aug; 267(24):17001-5. PubMed ID: 1324919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A peptide encoding the c-Jun delta domain inhibits the activity of a c-jun amino-terminal protein kinase.
    Adler V; Unlap T; Kraft AS
    J Biol Chem; 1994 Apr; 269(15):11186-91. PubMed ID: 8157646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogenic effect of delta deletion in v-Jun does not result from uncoupling Jun from JNK signaling.
    Sprowles A; Wisdom R
    Oncogene; 2003 Jan; 22(4):498-506. PubMed ID: 12555063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of v-Jun and c-Jun proteins on v-myb-transformed monoblasts.
    Sevcíková S; Soucek K; Kubala L; Bryja V; Smarda J
    Cell Mol Life Sci; 2002 Oct; 59(10):1690-705. PubMed ID: 12475180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. v-Jun represses c-jun proto-oncogene expression in vivo through a 12-O-tetradecanoylphorbol-13-acetate-responsive element in the proximal gene promoter.
    Hussain S; Kilbey A; Gillespie DA
    Cell Growth Differ; 1998 Aug; 9(8):677-86. PubMed ID: 9716184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear translocation of viral Jun but not of cellular Jun is cell cycle dependent.
    Chida K; Vogt PK
    Proc Natl Acad Sci U S A; 1992 May; 89(10):4290-4. PubMed ID: 1584763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-purification of mitogen-activated protein kinases with phorbol ester-induced c-Jun kinase activity in U937 leukaemic cells.
    Pulverer BJ; Hughes K; Franklin CC; Kraft AS; Leevers SJ; Woodgett JR
    Oncogene; 1993 Feb; 8(2):407-15. PubMed ID: 8426747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylation of c-jun mediated by MAP kinases.
    Pulverer BJ; Kyriakis JM; Avruch J; Nikolakaki E; Woodgett JR
    Nature; 1991 Oct; 353(6345):670-4. PubMed ID: 1922387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upstream regions of the c-jun promoter regulate phorbol ester-induced transcription in U937 leukemic cells.
    Unlap T; Franklin CC; Wagner F; Kraft AS
    Nucleic Acids Res; 1992 Feb; 20(4):897-902. PubMed ID: 1542579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional activation by the v-Jun oncoprotein is independent of positive regulatory phosphorylation.
    Black EJ; Catling AD; Woodgett JR; Kilbey A; Gillespie DA
    Oncogene; 1994 Aug; 9(8):2363-8. PubMed ID: 8036019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential and antagonistic effects of v-Jun and c-Jun.
    Gao M; Morgan I; Vogt PK
    Cancer Res; 1996 Sep; 56(18):4229-35. PubMed ID: 8797597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constitutively active MAP kinase kinase (MEK1) stimulates SAP kinase and c-Jun transcriptional activity in U937 human leukemic cells.
    Franklin CC; Kraft AS
    Oncogene; 1995 Dec; 11(11):2365-74. PubMed ID: 8570188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of chronic phorbol ester treatment on protein kinase C activity, content, and gene expression in the human monoblastoid U937 cell.
    Ways DK; Qin W; Garris TO; Chen J; Hao E; Cooper DR; Usala SJ; Parker PJ; Cook PP
    Cell Growth Differ; 1994 Feb; 5(2):161-9. PubMed ID: 8180129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An oncogenic mutation uncouples the v-Jun oncoprotein from positive regulation by the SAPK/JNK pathway in vivo.
    May GH; Funk M; Black EJ; Clark W; Hussain S; Woodgett JR; Gillespie DA
    Curr Biol; 1998 Jan; 8(2):117-20. PubMed ID: 9427647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ubiquitin-dependent c-Jun degradation in vivo is mediated by the delta domain.
    Treier M; Staszewski LM; Bohmann D
    Cell; 1994 Sep; 78(5):787-98. PubMed ID: 8087846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The avian cellular homolog of the oncogene jun.
    Nishimura T; Vogt PK
    Oncogene; 1988 Dec; 3(6):659-63. PubMed ID: 2577867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The v-Jun point mutation allows c-Jun to escape GSK3-dependent recognition and destruction by the Fbw7 ubiquitin ligase.
    Wei W; Jin J; Schlisio S; Harper JW; Kaelin WG
    Cancer Cell; 2005 Jul; 8(1):25-33. PubMed ID: 16023596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo viral and cellular Jun complexes exhibit differential interaction with a number of in vitro generated 'AP-1- and CREB-like' target sequences.
    Hadman M; Loo M; Bos TJ
    Oncogene; 1993 Jul; 8(7):1895-903. PubMed ID: 8510933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.